Next, we measured RRM2 serum levels in NSCLC patients and healthy controls by ELISA, while the serum levels of CEA, CYFRA21-1, NSE, and ProGRP were analyzed by ECLIAs. This evidence concerns the gene ENO2 and non-small cell lung carcinoma.